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Interleukin-12 (IL-12) is involved in cellular immune responses against intracellular pathogens by promoting the
generation of T naive in T helper 1 (Th1) cells and by increasing interferon-gamma (IFN-gamma) production from T
and natural killer (NK) cells. A defective induction of a Th1 response may lead to a higher risk of infections, and, in
particular, infections due to typical and atypical Mycobacteria. We report on the case of a girl with suffering from
recurrent bronchopneumonia associated with very high serum IgE levels, who exhibited a profound impairment of
the Th1 generation associated with a novel mutation in the exon 5 of the IL-12R β1 gene (R156H). Our data
suggest that in children with severe and recurrent infections, even in the absence of a mycobacterial infection,
functional and/or genetic alterations of the molecular mechanisms governing Th1/Th2 homeostasis might be
responsible for an atypical immunodeficiency and, therefore, should be investigated in these patients.
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Primary congenital immunodeficiencies encompass a
wide spectrum of distinct clinical entities, which differ
in either pathogenetic mechanism or clinical features.
Recently, several novel syndromes with unusual phe-
notypes have been described [1,2]. However, in a num-
ber of patients suffering from severe and sometimes
life-threatening infections, in which an immunological
disorder is suspected, the underlying genetic defect re-
sponsible for the immunodeficiency still remains to be
elucidated [3]. Recently, a higher susceptibility to intra-
cellular pathogens and, in particular, atypical mycobac-
terial and salmonella infections has been described in
patients with genetic alterations of the IL-12 receptor
(IL-12R) [4-9]. IL-12 stimulates cellular immune res-
ponses against intracellular pathogens by promoting the
generation of T naive in T helper 1 (Th1) cells and by
increasing interferon-gamma (IFN-gamma) production* Correspondence: pignata@unina.it
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reproduction in any medium, provided the orfrom T and natural killer (NK) cells. Induction of a
Th1 response and cell cycle progression mostly relies
on the expression of a high affinity IL-12R, consisting
of β1 and β2 chains [10-15]. A few genetic alterations
of β1 chain have already been reported in patients suf-
fering of mycobacterial infections [5,6].Case presentation
A 8-year-old girl was referred to the our Department be-
cause of a history of recurrent pneumonia (4 episodes
over 2 years). At the age of 4 years and 8 months she
had suffered from the first episode of middle lobar bron-
chopneumonia requiring hospitalization. In that occa-
sion the total IgE serum levels were 3350 kU/l. One
month later, she was hospitalized for a second broncho-
pneumonia episode interesting both lungs followed by
persistent cough for more than a month. These episodes
were responsive to antibiotic therapy. Subsequently, she
had suffered from 2 additional bronchopneumonia epi-
sodes in distinct lung area, successfully treated with par-
enteral antibiotic therapy. Conventional x-ray and high
resolution computed tomography of the chest revealed
multiple focal consolidations in both lungs, confirmedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cillus was not found in the sputum examination. In
one occasion, Haemophilus influenzae was isolated on
sputum culture. Weight and height growth was in the
normal range. No infections in other organs were
reported. The routine immunological evaluation revealed
normal IgG and IgA, but very high serum IgE levels
(> 2000 kU/l), confirmed in several occasions during
the 2 years follow-up. Specific IgE toward Dermato-
phagoides farinae and pteronyss, olive, herb vitriol and
Parietaria judaica were detected. Prick test were posi-
tive (ponf > 0.3 × 0.4 cm) for Dermatophagoides farinae
and pteronyss, hair of dog, Parietaria and olive, thus
confirming a multiple sensitivity. The patient showed a
proper antibody specific response as demonstrated by
the presence of IgG antibody serum levels, tested by
immuno-enzymatic method, against B-hepatitis, paro-
titis and German measles viruses. Serum IgG, IgA e
IgM levels were always in the normal range. The im-
munophenotype valuation revealed normal number and
percentage of the lymphocyte subpopulations studied
(Table 1).
The patient’s family history was notable for the pres-
ence of allergic disorders in both lineages. In particular,
her mother and grandmother had a history of allergic
rhinitis, while her father had urticaria. A maternal aunt
died at 2 years of age by whooping-cough and a mater-
nal uncle died at 16 months by a severe not better speci-
fied respiratory infection. A paternal aunt and her
daughter had a history of allergic rhinitis.
We first determined the proliferative response of
PBMC to CD3 cross-linking, that mimics in vivo antigen
exposure, performed at optimal (1 ng/ml) or suboptimalTable 1 Immunonological parameters







CD4-CD8-TCR α/β+ 2.3 88.32
CD4-CD8-TCR g/d+ 2.2 84.48
Specific antibody responses IgG IgM
B-hepatitis virus Present Absent
Parotidis virus Present Absent







PMA + iono 22458 ± 11013 32159± 27858
CD3 X-L 800± 68 29500 ± 3000(0.3 ng/ml) antibody concentration. The proliferation
at the maximal dosage was significantly lower in the
patient than in the controls (mean ± SE were:
800 ± 68 cpm and 29500 ± 3000 cpm in the proband
and controls, respectively). Since a proper immune re-
sponse to pathogens requires a Th1 induction and this
process determines up-regulation of the expression of
the IL-12R β2 chain, we evaluated mRNA expression of
this molecule after mitogen stimulation of PBMC
in vitro. No expression of IL-12R β2 transcript was
found in patient’s cells (Figure 1A), differently from the
controls. IL-12R β1 was expressed at normal levels
(Figure 1B).
At molecular level, gene sequencing of IL-12R β2 gene
revealed a missense mutation (G to A) at nucleotide 531
in the exon 5 in heterozygosity, resulting in the substitu-
tion of arginine (CGT) with histidine (CAT) in the extra-
cellular domain of the receptor at the same aminoacid
position 156 (designed R156H) (Figure 2). The mutation
was not a polymorphism since was not found in 100
chromosomes from unrelated individuals. This G to A
transition creates a new restriction site for NdeI enzyme
(data not shown).
Discussion
The case here reported indicates that alterations of the
induction of a proper Th1 response may be associated
with an atypical immunodeficiency characterized by high
susceptibility to infections. The functional response of
lymphocytes to IL-12 depends on the expression of a
high affinity IL-12 receptor on Th1 and NK cells. The











Figure 1 mRNA expression of IL-12R β2 chain after mitogen
stimulation of PBMC in vitro. (A) No expression of IL-12R β2
transcript was found in patient’s cells, differently from the controls.























Figure 2 gene sequencing of IL-12R β2 gene. At molecular level, gene sequencing of IL-12R β2 gene revealed a missense mutation (G to A) at
nucleotide 531 in the exon 5 in heterozygosity, resulting in the substitution of arginine (CGT) with histidine (CAT) in the extracellular domain of
the receptor at the same aminoacid position 156 (designed R156H).
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protein (gp) 130 [11,17]. The complete IL-12R is
thought to be associated with the development, being
expressed on human naive T cells during differentiation
to Th1 but not to Th2. Therefore, the expression of
these molecules is generally considered as a marker of
Th1 dominated response [11-13,16]. Th1 cells produce
IFN-gamma and IL-2 and, predominantly, promote cell
mediate immune responses against intracellular patho-
gens [18,19]. In a previous study, we provided evidence
of altered IL-12/IL-12R signaling in patients with very
high IgE levels, suggestive of an impaired Th1 induction
[20]. A defective induction of a Th1 response in patients
may lead to a higher risk of infections, thus worsening
the overall outcome of patients with very high IgE levels.
In the case herein described a genetic alteration of the
IL-12R β1 has been found in heterozygosity. Whether
this alteration is really responsible for the phenotype
remains to be definitively demonstrated with further
molecular and functional studies. However, it should be
noted that patients with homozygous alterations of the
same gene have already been reported, being affected
with a more severe clinical phenotype and selective sus-
ceptibility to mycobacterial infections [5,6]. Based on
this clinical observation, we suggest that a better under-
standing of the molecular mechanisms governing Th1/
Th2 homeostasis may help recognize novel clinical phe-
notypes of atypical immunodeficiencies.Consent
Written informed consent was obtained from the parents
of the patient for publication of this Case report and any
accompanying images.
Abbreviations
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